| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/29/2003 | EP1278523A2 Combination of progesterone and mifepristone for cancer therapy |
| 01/29/2003 | EP1278516A1 Powders for use in a dry powder inhaler |
| 01/29/2003 | EP1278515A1 Pharmaceutical formulation comprising carrier beads coated with a layer of valaciclovir |
| 01/29/2003 | EP1278514A1 Microencapsulated and controlled-release herbal formulations |
| 01/29/2003 | EP1278513A2 A core formulation |
| 01/29/2003 | EP1278512A2 Cationic diagnostic, imaging and therapeutic agents associated with activated vascular sites |
| 01/29/2003 | EP1278511A1 Use of a lacrophyl preparation in eye-drops containing therapeutically active compounds |
| 01/29/2003 | EP1278496A1 Methods and apparatus for controlled heat to regulate transdermal delivery of medical substances |
| 01/29/2003 | EP1278495A1 Topical compositions containing prostaglandin e 1? |
| 01/29/2003 | EP1278494A1 Device and method for treating urinary incontinence in females |
| 01/29/2003 | EP1278453A2 Fiber optic probe placement guide |
| 01/29/2003 | EP1278418A1 Iodine-propylene glycol teat dip |
| 01/29/2003 | EP1265570A4 Soluble keratin peptide |
| 01/29/2003 | EP1182931A4 Stable biocidal compositions |
| 01/29/2003 | EP1119334B1 Two chamber cartridge for atomizers |
| 01/29/2003 | EP1024815B1 Pharmaceutical compositions for oral administration of molecular iodine |
| 01/29/2003 | EP1012204B1 Spherical microparticles containing linear polysaccharides |
| 01/29/2003 | EP0950012B1 Package of sheet-type patches |
| 01/29/2003 | EP0868171B1 Implants with phased release of medicaments |
| 01/29/2003 | EP0706378B1 New pharmaceutical formulation |
| 01/29/2003 | EP0666737B1 Transdermal delivery of the eutomer of a chiral drug |
| 01/29/2003 | EP0572560B1 Use of pharmaceutical compounds in the treatment of symptoms of disorders related to neurological diseases and etiologically related symptomology |
| 01/29/2003 | CN1394141A Fulvestrant formulation |
| 01/29/2003 | CN1394140A Prostaglandin compositions and method of treatment for male erectile dysfunction |
| 01/29/2003 | CN1394136A Instant granules and process for their formulation |
| 01/29/2003 | CN1393266A Slow-releasing hirudin medicine applied orally |
| 01/29/2003 | CN1393265A Method for reducing fasting blood-glucose of diabetic and weight |
| 01/29/2003 | CN1393252A Ointment for treating burn and its preparing process |
| 01/29/2003 | CN1393248A Extracting process and application of active component of pueraria root |
| 01/29/2003 | CN1393247A Chinese-medicinal ointment for treating burn and scald |
| 01/29/2003 | CN1393245A Plaster for treating lumbar intervertebral disk protrusion |
| 01/29/2003 | CN1393242A Plaster for treating mastoplasia |
| 01/29/2003 | CN1393236A Medicine 'Aibixiao' for treating cancer |
| 01/29/2003 | CN1393235A Plaster for treating facial neuritis and its preparing process |
| 01/29/2003 | CN1393231A Antisanility health-care cream and its preparing process |
| 01/29/2003 | CN1393220A Slow releasing microspheres of transcutaneous huperzine A and its derivative or salt for injection and its preparing process |
| 01/29/2003 | CN1393218A Biodegradable durable medicine releasing system |
| 01/29/2003 | CN1393217A Release system for hydrophilic medicines containing polyether |
| 01/29/2003 | CN1393216A Superfine Chinese patent medicine and its preparing process |
| 01/29/2003 | CN1393215A process for preparing medicine from raw materials chosen by user itself |
| 01/29/2003 | CN1393214A Face-beautifying and spot-removing cream and its preparing process |
| 01/29/2003 | CN1393208A Medical pad for preventing and treating pile |
| 01/29/2003 | CN1393171A Nutritive fruit-vegetable tablet |
| 01/29/2003 | CN1099893C Sustained-release preparation |
| 01/29/2003 | CN1099868C Vesicles with controlled release of actives |
| 01/29/2003 | CN1099843C Aquo composition for preparing optical transparent product, preparing process and usage thereof |
| 01/28/2003 | US6512139 Oxidation inhibitors in prostane derivatives |
| 01/28/2003 | US6512072 Formulation for depositing a film on a substrate comprising 5 to79.9 wt. % of an alkylene trialkoxy terminated polysiloxane; 0.01 to 5 wt. % of a catalyst; 20 to 94.99 to wt % of a volatile diluent, and, optionally, 0.01 to 5 wt. % of an |
| 01/28/2003 | US6512023 An adhesive composition includes a polymerizable adhesive monomer, at least one vapor phase stabilizer, and at least one liquid phase stabilizer. The combination of at least one vapor phase stabilizer and at least one liquid phase |
| 01/28/2003 | US6512010 Formulations for the administration of fluoxetine |
| 01/28/2003 | US6511996 Suitable compounds for i.v.-administration due to their intrinsic properties, such as high stability and high solubility in water |
| 01/28/2003 | US6511972 Stable oral pharmaceutical formulations comprising amoxycillin trihydrate and potassium clavulanate |
| 01/28/2003 | US6511960 Also cromolyn salts or esters; may be in combination with a corticosteroid; may also contain an antiphlogistic compound and hyaluronic acid |
| 01/28/2003 | US6511949 Ophthalmic composition with regulated viscosity |
| 01/28/2003 | US6511847 Recombinant adenovirus using liposome-mediated cotransfection and the direct observation of a cytopathic effect in the transfected cells; tumor suppressor gene |
| 01/28/2003 | US6511749 Preparation of multiwall polymeric microcapsules from hydrophilic polymers |
| 01/28/2003 | US6511712 Methods using dry powder deposition apparatuses |
| 01/28/2003 | US6511681 Solubility and bioavailability of azole antifungal medicaments |
| 01/28/2003 | US6511680 Anti-inflammatory pharmaceutical formulations |
| 01/28/2003 | US6511679 Breath freshening comestible product and method of controlling breath malodor |
| 01/28/2003 | US6511678 Controlled release formulation of divalproex sodium |
| 01/28/2003 | US6511677 Polymerizable fatty acids, phospholipids and polymerized liposomes therefrom |
| 01/28/2003 | US6511676 Forming cisplatin and ethanol buffered solution; combining with a negatively charged phosphatidyl glycerol lipid deriva-tive; able to reach primary tumors and their metastases after intravenous injection; breast and prostate cancer |
| 01/28/2003 | US6511675 Dietary supplements |
| 01/28/2003 | US6511668 Silicon oxide powder and process for manufacturing thereof, and cosmetic preparation, micelle holding powder, and perfume holding powder, using the same |
| 01/28/2003 | US6511661 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract |
| 01/28/2003 | US6511660 Ophthalmic drug delivery formulations and method for preparing the same |
| 01/28/2003 | US6511653 Fluorocarbon polymer coating comprises the monomers tetrafluoroethylene, hexafluoropropylene, perfluoroalkoxyalkylene, and vinylidene fluoride; fluorocarbon propellant |
| 01/28/2003 | US6511652 Fluorocarbon polymer coating comprises the monomers tetrafluoroethylene, hexafluoropropylene, perfluoroalkoxyalkylene, and vinylidene fluoride; fluorocarbon propellant |
| 01/28/2003 | US6511477 Administering encapsulated drugs such as antiarrythmia agents, so that there is preferential transportation due to particle sizes by lymphs; biodegradable time-release agents for prophylaxis of cardiovascular disorders |
| 01/28/2003 | US6511473 Implantable bioartificial active secretion system |
| 01/28/2003 | US6511453 Device for controlled anaesthesia, analgesia and/or sedation |
| 01/28/2003 | US6510969 Valve for aerosol container |
| 01/28/2003 | CA2307101C Pharmaceutical articles of manufacture comprising selective phosphodiesterase inhibitors for the treatment of sexual dysfunction |
| 01/28/2003 | CA2297560C Nanoemulsion based alkoxyle alkenyle succinates or alkoxyle glucose alkenyle succinates and it's use in cosmetics, dermatological, ophtalmological and/or pharmaceutical |
| 01/28/2003 | CA2284910C Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 01/28/2003 | CA2271569C Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 01/28/2003 | CA2245269C Solid pharmaceutical dispersions with enhanced bioavailability |
| 01/28/2003 | CA2231648C Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems |
| 01/28/2003 | CA2219289C Tamper evident pharmaceutical dosage form |
| 01/28/2003 | CA2196295C Stable vitamin a |
| 01/28/2003 | CA2163003C Solubilizer and external preparations containing the same |
| 01/28/2003 | CA2127553C Peptides with organo-protective activity, process for their preparation and their use in the therapy |
| 01/28/2003 | CA2078869C Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use |
| 01/25/2003 | CA2395614A1 Formulation and process for the preparation of rapid dispersion spheroids capable of being heavily titrated |
| 01/24/2003 | CA2369210A1 Medical patch with burstable partition |
| 01/23/2003 | WO2003006993A2 Gel compositions |
| 01/23/2003 | WO2003006608A2 Enhancement of transfection of dna into the liver |
| 01/23/2003 | WO2003006568A1 Pyrrolidonoethyl (meth)acrylate containing pressure sensitive adhesive compositions |
| 01/23/2003 | WO2003006225A1 Tablet cryotechnology |
| 01/23/2003 | WO2003006177A1 Method and device for coating pharmaceutical products |
| 01/23/2003 | WO2003006066A1 Mixed complexes for masking the taste of bitter active substances |
| 01/23/2003 | WO2003006064A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant |
| 01/23/2003 | WO2003006063A2 Formulation comprising fulvestrant |
| 01/23/2003 | WO2003006054A1 Pharmaceutically stable hemostatic compositions |
| 01/23/2003 | WO2003006053A1 HUMAN INTERFERON-β FORMULATIONS |
| 01/23/2003 | WO2003006052A1 Sustained-release compositions for injection and process for producing the same |
| 01/23/2003 | WO2003006049A1 Gonadotropin releasing hormone antagonists in gel-forming concentrations |
| 01/23/2003 | WO2003006046A1 Use of antimicrobial peptides as preservatives in ophthalmic preparations including solutions emulsions and suspensions |
| 01/23/2003 | WO2003006045A2 Cxcl10 treatment of secondary tissue degeneration |